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tag was obtained from OriGene (catalogue no. TP303009). Specificity of the primary antibodies was verified by evaluating cross-reactivity of the CES1 and CES2 primary antibodies against the highest concentration of recombinant CES2 and CES1 protein used in the analysis, respectively. Horseradish-conjugated donkey anti-rabbit IgG was obtained from GE Healthcare Lifesciences (Piscataway NJ) (catalogue no. NA934-100UL). Pre-stained protein molecular weight markers were obtained from Invitrogen (Grand Island NY).
Western blot analysis. Aliquots of individual microsomal and cytosolic tissue preparations
were fractionated by SDS-polyacrylamide gel electrophoresis along with a range of CES1 and CES2 purified, recombinant protein concentrations and molecular weight standards essentially as described earlier (Koukouritaki et al. 2002) . Fractionated proteins subsequently were transferred to a nitrocellulose-based membrane (Hybond, GE Healthcare Lifesciences) by electrophoresis. The membrane was incubated with either the CES1 (1:10,000 dilution) or CES2 (1:2,500 dilution) polyclonal antibody, followed by the horseradish peroxidase-conjugated secondary antibody (1:10,000 dilution). Visualization was accomplished using enhanced chemiluminescence (GE Healthcare Lifesciences ECL Plus Detection System) and the ChemiDoc CCD Imaging Analysis system (Bio-Rad, Hercules CA). Linear regression analysis was used to quantify the amount of both CES1 and CES2 protein in each tissue fraction based on the signals observed with the respective purified, recombinant proteins. An r 2 ≥ 0.95 was accepted as evidence of assay linearity. The interday coefficients of variation for microsomal and cytosolic CES1 measurements were 7.3% and 6.1%, respectively (N=5 replicates, each).
The interday coefficients for variation for microsomal and cytosolic CES2 measurements were 3.2 and 4.1% (n= 5 replicates, each).
Statistical Analysis. Scatter plots of protein specific content as a function of age were used to evaluate overall trends. Regression tree analysis using CART version 6 (Salford Systems, San DMD #68957 Diego, CA, USA) was used to evaluate possible age threshold effects. Least average deviation from the median was used to define the tree nodes. Statistical comparisons between age groups were performed using Kruskal-Wallis nonparametric tests, followed by stepwise stepdown comparisons of all pairs of data sets (IBM SPSS Statistics 19; SPSS Inc., Chicago, IL).
Other variables of interest were compared using nonparametric testing. Linear regression was used to test relationships between continuous variables with the strength of the r 2 (i.e., proximity to 1) and the p value being considered highly relevant. ANOVA and stepwise regression testing were used to assess the multiple factors potentially associated with enzyme content.
RESULTS
Detection of microsomal and cytosolic CES proteins. The developmental expression
pattern of the human hepatic CES enzymes was determined by SDS-PAGE and western blot analysis of microsomal and cytosolic samples prepared from a bank of 165 human pediatric liver samples donated by individuals over a wide postnatal age range at the time of death. For CES1, western blotting revealed a single, major immunoreactive band in both the microsomal and cytosolic fractions with an apparent molecular mass near 61 kDa, corresponding to the intact CES1 protein ( Figure 1A and 1B) and on re-blotting, an apparent molecular mass near 69 kDa, corresponding to the intact CES2 protein ( Figure 1C and 1D) . No cross-reactivity between the anti-CES1 antibody and CES2 protein ( Figure 1A , Lanes 2-6) or between the anti-CES2
antibody and CES1 protein was observed ( Figure 1D , Lanes 13-17).
Overall CES variation and demographic variables. Both CES1 and CES2 were detectable in the majority of samples. With outliers included, microsomal and cytosolic CES1 varied 30-and 70-fold, whereas CES2 varied 11-and 8-fold, respectively. However, without considering extreme values, the overall distribution of CES content for the entire sample varied about 10- Based on both classification tree analysis and confirmatory Kruskal Wallis testing, microsomal CES1 activity was lower among samples from subjects younger than 3 weeks of age compared to the rest of the population. This age differential appeared to be driven by the onset of expression during the first 3 weeks of life as no subject older than 18 days of age had non-detectable microsomal CES1 expression (Figures 2A and B) . A second node at 6 years was identified by the initial tree analysis, but was not statistically significant (p=0.13) when considered in conjunction with the 3 week node. Thus, samples from individuals between birth and 3 weeks of age [N=36, median value (Interquartile Range; IQR) = 6.27 (4.2-13.4) Considering the population as a whole, as CES1 microsomal content increased, there was a corresponding increase in the cytosolic CES1 content (see trend in Figure 3 ). However, when microsomal and cytosolic CES1 content were compared within individuals, only a modest relationship was observed (r 2 =0.207, p<0.001, linear regression) (data not shown). Both microsomal and cytosolic CES1 was measured in 160/165 samples and of these, the enzyme was detectable in one or the other compartment in 154 samples. Microsomal CES1 content was greater than cytosolic CES1 content in 87/154 samples with a median difference of 5.8 pmol/mg protein (range = 0.1 to 59.5 pmol/mg protein). Cytosolic CES1 content was greater than microsomal CES1 content in 67/154 samples with a median difference of 5.5 pmol/mg protein (range = 0.1 to 63.3 pmol/mg protein). Taken together, these data argue against microsomal content determining cytosolic content and also suggest CES1 content in the two matrices is independently regulated.
Human CES2 Ontogeny. Similar to human CES 1, CES 2 also increased with age with variation apparent across the age range spectrum. The most marked changes occurred during 
DISCUSSION
The results of this project confirm that human hepatic microsomal and cytosolic CES1
and CES2 expression is developmentally regulated based on the strong association between postnatal age and quantitatively measured protein values. For both enzymes, expression was markedly lower among infants 3 weeks of age or less compared to older infants and children.
Of note, for microsomal CES1, all samples exhibited some expression after three weeks, whereas the universal onset of CES2 expression appeared somewhat later or its expression was suppressed by an unidentified mechanism in a small number of samples. After three weeks of age, ongoing developmental changes varied by enzyme and by compartment.
Microsomal CES1 and cytosolic CES2 did not exhibit additional age related differences. In contrast, for microsomal CES2 and cytosolic CES1, the samples from children over the age of six exhibited statistically significantly greater expression than those between 3 weeks and 6 years of age. This suggests that significant developmental changes continue during the window between 3 weeks and 6 years. This may be particularly relevant for CES1 given its high expression levels in the liver. However, the rate of change during this time appears modest as reflected in the relatively small numerical change over a wide time interval in comparison to the relatively steep surge in expression that occurs during the first three weeks after birth.
This article has not been copyedited and formatted. The final version may differ from this version. belong to the class 3 group of enzymes involved in drug and toxicant disposition, i.e., they exhibit low to no expression in the fetus and that expression increases substantially during the first months to 2 years of life (Hines 2012).
Over the entire population, microsomal and cytosolic CES1 varied about 30-and 70-fold, respectively, whereas microsomal and cytosolic CES2 varied about 11-and 8-fold, respectively.
In both compartments, the median CES1 value varied by about 3-to 3.5-fold across the three age groups, whereas the median CES2 value varied by 1.5-to 2.5-fold. Importantly, the within age bracket variation was substantive. We speculate that this within age bracket variability is This study is limited by the absence of CES1 and CES2 activity data for each sample.
Such data is desirable if highly specific substrates are available and assays can be developed with sufficient sensitivity to allow an adequate signal to noise ratio with the small amount of protein available for each sample in the tissue bank; this was not the case for these enzymes.
However, past experiments performed to evaluate the developmental trajectories of other enzymes employing this same tissue bank and where highly sensitive and specific activity assays were available demonstrated excellent correlation between enzyme specific content and specific activity (Koukouritaki et al., 2004; Li et al., 2012) . This past experience provides some confidence that a similar relationship would be observed for CES1 and CES2. A second limitation is that the sample set did not include tissue from adults (>18 years of age) as a comparator. Indeed, because the tissue bank was designed to have maximum power to detect differences at younger ages, the median age of the entire sample set was 3.5 months and of the samples >3 weeks of age, 9.6 months. Thus, one might expect the reported median CES1 and CES2 protein levels in the greater than 3 weeks age bracket to be less than one would observed in adults greater than 18 years of age. Consistent with this expectation, Shi et al.
(2011) reported an approximate 2-fold increase in mean relative CES1 protein levels in hepatic S9 fractions from donor samples between 5 weeks and 6.5 months of age and adults (>18 years of age). Similar results have recently been reported for CES2 (Chen et al. 2015) .
The data from this project will be used in conjunction with available data on the ontogeny of other relevant enzymes and numerous physiologic variables to develop high quality physiologically-based pharmacokinetic models for specific CES1 and CES2 substrates.
Importantly, because of the somewhat unique dual compartment localization of the hepatic CES enzymes, such models should consider the contribution of both compartments to clearance.
The anticipated simulations will be valuable for therapeutics, but will be critical for assessing the safety of compounds such as the pyrethroids and pyrethrins which cannot be directly studied in children. As such, these new data represent a significant advance over existing data which were insufficient for this purpose both because of the poor time resolution and use of relative units of measure. Relationship between cytosolic CES1 and age in postmortem cytosolic liver samples from a subset of subjects less than one year of age (N=101). The vertical line represents the time point selected by classification trees as an appropriate age grouping (3 weeks). Fig. 3 . Summary of microsomal (white boxes) and cytosolic (gray boxes) human CES1 developmental expression pattern. CES1 specific content as a function of age was grouped using classification tree analysis to minimize differences within while maximizing differences between age brackets. The resulting data are shown as box and whisker plots in which the horizontal bar represents median CES1 content, boxes the upper and lower quartiles, and vertical bars the 5th to 95th percentiles. Outliers, defined as having specific contents outside 1.5 times the 25th to 75th percentiles are shown as open circles, but were excluded from the analyses except for determining absolute ranges in expression. The youngest age group differed significantly from the other two for both matrices (p < 0.001, each comparison; Kruskal Wallis testing), whereas the middle age group was modestly significantly different from the older group in CES1 cytosolic content (p=0.05), but did not differ in CES1 microsomal content (p=0.13). developmental expression pattern. CES2 specific content as a function of age was grouped using classification regression trees to minimize differences within age groups while maximizing differences between age brackets. The resulting data are shown as box and whisker plots in which the horizontal bar represents median CES2 content, boxes are the upper and lower quartiles, and vertical bars the 5th to 95th percentiles. Outliers, defined as having specific contents outside 1.5 times the 25th to 75th percentiles are shown as open circles, but were excluded from the analyses except for reporting absolute expression ranges. The youngest age group differed significantly from the other two for both matrices (***p < 0.001, each comparison, Kruskal Wallis testing) whereas the middle age group was significantly different from the older group in CES1 microsomal content (p=<0.001), but did not differ in CES1 cytosolic content (p=0.26).
This article has not been copyedited and formatted. The final version may differ from this version. 1 To ensure good age representation and adequate power, target sample sizes for birth to 30 days, greater than 30 days to1 year, greater than 1 year to 5 years, greater than 5 years to 10 years, and greater than 10 years to 18 years age brackets were developed based on data from the existing literature on drug and toxicant metabolizing enzyme ontogeny. Samples sizes were sufficient to provide at least 80% power to detect a 1 standard deviation change in enzyme specific content between age brackets assuming α =0.05.
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